ATE297755T1 - Verwendung von lactoferrin in der behandlung von beschwerden, die von allergenen verursacht sind - Google Patents
Verwendung von lactoferrin in der behandlung von beschwerden, die von allergenen verursacht sindInfo
- Publication number
- ATE297755T1 ATE297755T1 AT98915471T AT98915471T ATE297755T1 AT E297755 T1 ATE297755 T1 AT E297755T1 AT 98915471 T AT98915471 T AT 98915471T AT 98915471 T AT98915471 T AT 98915471T AT E297755 T1 ATE297755 T1 AT E297755T1
- Authority
- AT
- Austria
- Prior art keywords
- lactoferrin
- allergens
- treatment
- conditions caused
- asthma
- Prior art date
Links
- 102000010445 Lactoferrin Human genes 0.000 title 1
- 108010063045 Lactoferrin Proteins 0.000 title 1
- 239000013566 allergen Substances 0.000 title 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 title 1
- 229940078795 lactoferrin Drugs 0.000 title 1
- 235000021242 lactoferrin Nutrition 0.000 title 1
- 206010040914 Skin reaction Diseases 0.000 abstract 1
- 230000000172 allergic effect Effects 0.000 abstract 1
- 206010003246 arthritis Diseases 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 208000010668 atopic eczema Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 230000007108 local immune response Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 231100000430 skin reaction Toxicity 0.000 abstract 1
- 230000035483 skin reaction Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4189097P | 1997-04-10 | 1997-04-10 | |
| PCT/US1998/007234 WO1998044940A1 (en) | 1997-04-10 | 1998-04-10 | Use of lactoferin in the treatment of allergen induced disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE297755T1 true ATE297755T1 (de) | 2005-07-15 |
Family
ID=21918897
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98915471T ATE297755T1 (de) | 1997-04-10 | 1998-04-10 | Verwendung von lactoferrin in der behandlung von beschwerden, die von allergenen verursacht sind |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20030190303A1 (https=) |
| EP (1) | EP0979099B1 (https=) |
| JP (1) | JP2001519815A (https=) |
| CN (1) | CN1262625A (https=) |
| AT (1) | ATE297755T1 (https=) |
| AU (1) | AU747385C (https=) |
| CA (1) | CA2285960A1 (https=) |
| DE (1) | DE69830582T2 (https=) |
| ES (1) | ES2245028T3 (https=) |
| IL (1) | IL132293A0 (https=) |
| NZ (1) | NZ500712A (https=) |
| WO (1) | WO1998044940A1 (https=) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL336626A1 (en) * | 1997-05-03 | 2000-07-03 | Regents Board Of | Methods of preventing and treating traumatic loss of metabolic equlibrium among human beings and animals |
| US6399570B1 (en) * | 1999-02-05 | 2002-06-04 | Agennix, Inc. | Antimicrobial/endotoxin neutralizing polypeptide |
| US6808902B1 (en) | 1999-11-12 | 2004-10-26 | Amgen Inc. | Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules |
| AU782539B2 (en) * | 2000-01-14 | 2005-08-04 | Meiji Dairies Corporation | Antigen-specific IgE antibody production inhibitors |
| RU2165769C1 (ru) * | 2000-07-13 | 2001-04-27 | Якубовская Раиса Ивановна | Антибактериальный, антиоксидантный, иммуномодулирующий и антиканцерогенный препарат и способ его применения |
| PH12012502440A1 (en) | 2001-06-26 | 2013-06-17 | Amgen Inc | Antibodies to opgl |
| CA2471766C (en) * | 2001-12-28 | 2011-01-11 | Nrl Pharma, Inc. | Compositions for improving lipid metabolism |
| EP2543385A1 (en) | 2002-01-21 | 2013-01-09 | NRL Pharma, Inc. | Novel analgesics |
| CN100467059C (zh) | 2002-05-10 | 2009-03-11 | 阿根尼克斯有限公司 | 乳铁蛋白在治疗恶性肿瘤疾病中的用途 |
| US7238661B2 (en) * | 2002-05-24 | 2007-07-03 | Agennix, Inc. | Oral lactoferrin in the treatment of respiratory disorders |
| CA2824167C (en) | 2002-09-06 | 2018-09-25 | Amgen Inc. | Therapeutic human anti-il-1r1 monoclonal antibody |
| DE60335997D1 (de) * | 2002-09-16 | 2011-03-24 | Agennix Inc | Lactoferrin-zusammensetzungen und verfahren zur behandlung von diabetischen ulcus |
| CA2508912A1 (en) * | 2002-12-06 | 2004-06-24 | Agennix Incorporated | Oral lactoferrin in the treatment of sepsis |
| AU2003296447A1 (en) | 2002-12-10 | 2004-06-30 | Agennix Incorporated | Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease |
| US7439241B2 (en) * | 2003-05-27 | 2008-10-21 | Galderma Laboratories, Inc. | Compounds, formulations, and methods for treating or preventing rosacea |
| US8105615B2 (en) * | 2003-06-06 | 2012-01-31 | Agennix Incorporated | Lactoferrin as an adjuvant in cancer vaccines |
| WO2005018542A2 (en) * | 2003-07-10 | 2005-03-03 | Agennix Incorporated | Use of lactoferrin in prophylaxis against infection and/or inflammation in immunosuppressed subjects |
| US20090203586A1 (en) * | 2004-06-11 | 2009-08-13 | Syngenta Limited | Method for ameliorating an inflammatory skin condition |
| WO2006047744A2 (en) | 2004-10-26 | 2006-05-04 | Agennix Incorporated | Compositions of lactoferrin related peptides and uses thereof |
| CN101166535A (zh) * | 2005-03-15 | 2008-04-23 | 坎皮纳荷兰控股有限责任公司 | 乳蛋白的皮肤病学应用 |
| US8178486B2 (en) * | 2005-07-21 | 2012-05-15 | Animal Technology Institute Taiwan | Method for promoting hair growth |
| EP1937298A4 (en) * | 2005-10-14 | 2009-11-11 | Auckland Uniservices Ltd | USE OF LACTOFERRIN FRAGMENTS AND HYDROLYSATES |
| JPWO2007049757A1 (ja) * | 2005-10-27 | 2009-04-30 | サンスター株式会社 | ラクトフェリンを含んだリポソームを含有する破骨細胞増加抑制剤、経口組成物及び骨疾患の予防又は治療剤 |
| EP3210618A1 (en) * | 2010-04-23 | 2017-08-30 | Probiotec Limited | Composition comprising lactoferrin and immunoglobulin for the treatment of eczema |
| CN102370964B (zh) * | 2010-08-16 | 2015-12-09 | 李兴德 | 白细胞介素受体拮抗蛋白在制备皮肤外用制剂中的应用 |
| IT201800002457A1 (it) * | 2018-02-07 | 2019-08-07 | Neilos S R L | Composizione per la prevenzione e il trattamento delle affezioni delle vie respiratorie |
| WO2020035482A1 (en) | 2018-08-13 | 2020-02-20 | Iltoo Pharma | Combination of interleukin-2 with an interleukin 1 inhibitor, conjugates and therapeutic uses thereof |
| PL4072322T3 (pl) * | 2019-12-11 | 2025-05-19 | N.V. Nutricia | Kompozycja do żywienia do poprawy sprawności układu odpornościowego |
| EP4526469A1 (en) | 2022-05-16 | 2025-03-26 | Institut National de la Santé et de la Recherche Médicale | Methods for assessing the exhaustion of hematopoietic stems cells induced by chronic inflammation |
| CN115737787B (zh) * | 2022-12-15 | 2024-04-19 | 四川大学 | 乳铁蛋白联合胆碱在制备预防和/或治疗阿尔兹海默症的药物中的用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2596986B1 (fr) * | 1986-04-11 | 1988-09-23 | Sederma Sa | Utilisation de la lactoferrine dans des preparations cosmetiques, antiradicaux libres |
| FR2641696B2 (fr) * | 1986-04-11 | 1991-03-08 | Sederma Sa | Utilisation d'un melange renfermant de la lactoferrine dans des preparations cosmetiques anti-radicaux libres |
| FR2685202B1 (fr) * | 1991-12-24 | 1995-03-24 | Sederma Sa | Nouvelle methode de traitement pharmaceutique et cosmetique pour la regulation de la seborrhee, de l'acne et de la flore cutanee. |
| JP3184923B2 (ja) * | 1992-01-08 | 2001-07-09 | ビオ セレ ラボラトワール エス ア | 抗リウマチ剤 |
| JPH05279266A (ja) * | 1992-04-02 | 1993-10-26 | Imuno Japan:Kk | 歯周病の治療・予防用医薬組成物 |
| JP3163171B2 (ja) * | 1992-07-15 | 2001-05-08 | 森永乳業株式会社 | ＩｇＡ産生促進剤 |
| JP3746081B2 (ja) * | 1994-02-24 | 2006-02-15 | 森永乳業株式会社 | 動物皮膚病治療剤 |
| JPH0859450A (ja) * | 1994-08-18 | 1996-03-05 | Kose Corp | 皮膚外用剤 |
| JP2832517B2 (ja) * | 1994-12-09 | 1998-12-09 | 雪印乳業株式会社 | 大腸菌付着阻止剤 |
| JP3911642B2 (ja) * | 1995-06-06 | 2007-05-09 | 株式会社加美乃素本舗 | 皮膚外用剤 |
| JP3888707B2 (ja) * | 1996-01-22 | 2007-03-07 | 森永乳業株式会社 | 血管新生病治療剤 |
| US6111081A (en) * | 1996-05-31 | 2000-08-29 | Baylor College Of Medicine | Lactoferrin variants and uses thereof |
-
1998
- 1998-04-10 EP EP98915471A patent/EP0979099B1/en not_active Expired - Lifetime
- 1998-04-10 ES ES98915471T patent/ES2245028T3/es not_active Expired - Lifetime
- 1998-04-10 CN CN98805584A patent/CN1262625A/zh active Pending
- 1998-04-10 CA CA002285960A patent/CA2285960A1/en not_active Abandoned
- 1998-04-10 NZ NZ500712A patent/NZ500712A/xx not_active IP Right Cessation
- 1998-04-10 AU AU69647/98A patent/AU747385C/en not_active Ceased
- 1998-04-10 JP JP54315498A patent/JP2001519815A/ja not_active Ceased
- 1998-04-10 WO PCT/US1998/007234 patent/WO1998044940A1/en not_active Ceased
- 1998-04-10 DE DE69830582T patent/DE69830582T2/de not_active Expired - Lifetime
- 1998-04-10 AT AT98915471T patent/ATE297755T1/de not_active IP Right Cessation
- 1998-04-10 IL IL13229398A patent/IL132293A0/xx not_active IP Right Cessation
- 1998-04-10 US US09/058,589 patent/US20030190303A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN1262625A (zh) | 2000-08-09 |
| NZ500712A (en) | 2002-10-25 |
| DE69830582T2 (de) | 2006-05-04 |
| AU6964798A (en) | 1998-10-30 |
| EP0979099B1 (en) | 2005-06-15 |
| AU747385B2 (en) | 2002-05-16 |
| WO1998044940A1 (en) | 1998-10-15 |
| CA2285960A1 (en) | 1998-10-15 |
| IL132293A0 (en) | 2001-03-19 |
| ES2245028T3 (es) | 2005-12-16 |
| JP2001519815A (ja) | 2001-10-23 |
| US20030190303A1 (en) | 2003-10-09 |
| EP0979099A1 (en) | 2000-02-16 |
| AU747385C (en) | 2003-01-30 |
| DE69830582D1 (de) | 2005-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE297755T1 (de) | Verwendung von lactoferrin in der behandlung von beschwerden, die von allergenen verursacht sind | |
| DE69830404D1 (de) | P38-inhibitoren | |
| KR100521829B1 (en) | Compositions and Methods for the Treatment of Alzheimer's Disease, Central Nervous System Injury, and Inflammatory Diseases | |
| FI935585A0 (fi) | Pyrrolopyrimidiner | |
| DE69726724D1 (de) | Tetrahydropteridine und pyridylpiperazine zur behandlung von neurologischen störungen | |
| MY132496A (en) | Inhibitors of p38 | |
| EP1043995A4 (en) | INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED ARYL AND HETEROARYL HETEROCYCLIC UREAS | |
| DE69729796D1 (de) | Verwendung von synergistischen zusammensetzungen von il-12 und ifn-alpha für die behandlung von infektiösen krankheiten | |
| DK0841898T3 (da) | Topiske sammensætninger, der har forbedret hudfornemmelse | |
| NZ502527A (en) | Catalytic monoclonal antibodies raised to proteins in aggregated form, and use to treat alzheimers, atherosclerosis, amyloidosis and prions disease | |
| BRPI0411784A (pt) | anticorpos contra interleucina -22 e usos para os mesmos | |
| BG110703A (en) | PHARMACEUTICAL COMPOSITION, INCLUDING HUMAN ANTIBODIES CONNECTING HUMAN TNF ALPHA AND HIS APPLICATION | |
| ATE126441T1 (de) | Pentigetide zur behandlung von nicht-ige- vermittelten entzündlichen erkrankungen. | |
| DE69316948D1 (de) | Lösliche Liganden für CD40 | |
| DE60238149D1 (de) | Arylsulfonamid-Derivate zur Verwendung als CCR3-Antagonisten bei der Behandlung von inflammatorischen und immunologischen Erkrankungen | |
| NO971902D0 (no) | Bindingsmidler til CD23 | |
| EP1558766A4 (en) | USE OF A33 ANTIGENES AND JAM IT | |
| YU113391A (sh) | 2,4 i 2,5 substituirani piridin-n oksidi i postupak za njihovu proizvodnju | |
| DE60228073D1 (de) | Adenosin-a1-rezeptorantagonisten zur behandlung von hypoxiebedingten lern- und gedächtnisstörungen | |
| ATE138567T1 (de) | Zusammensetzung und verfahren zur behandlung von schmerzvollen entzündlichen oder allergischen erkrankungen | |
| ATE260653T1 (de) | Verwendung von naaladase inhibitoren zur behandlung von angstzuständen und gedächtnisstörungen | |
| ATE210447T1 (de) | Verwendung von cck-b rezeptor antagonisten zur behandlung von schlafstörungen | |
| DK0989973T3 (da) | Chalconer med antiproliferativ aktivitet | |
| DE69524093D1 (de) | Kombination von prokoagulans und cytokin oder induktor seiner produktion für die behandlung von tumoren | |
| DE60023139D1 (de) | Verwendung von il6r- il6 chimären für die behandlung von neurodegenerativen erkankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |